Monitoring medication response

If the number of patients at each centre is small, doctors cannot gain experience in the study and they cannot compare the responses of patients to the study medications. Study monitors have to cover wide geographic area and large number of study-related personnel in order to monitor relatively small number of patients. This old practice might be expected to reduce the quality and credibility of the study. 

JOB SUMMARY Clinical pharmacists work closely with other health practitioners to meet the various needs of our patients. Pharmacists review and approve medication orders, monitor drug therapies, and provide drug information. Pharmacists supervise and direct support personnel. In the absence of the pharmacy manager, a clinical pharmacist may be required to assume the essential responsibilities and perform the duties of the pharmacy manager. 

Action Provide federal medical response assets and individual public health and medical personnel to assist in providing care for ill or injured victims at the location of a disaster or emergency. DMATs and Federal Medical Shelters can provide triage, medical or surgical stabilization, and continued monitoring and care of patients until they can be evacuated to locations where they will... 

Medium term (weeks -months) Monitor medication response Try different medications Ongoing physical healthcare CBT for psychosis Motivational interviewing around cannabis use Liaise with hostel and enployer Review benefits bcational training Input from faith group... 

Required medical surveillance, monitoring, removal, and reporting responsibilities for applicable standards are assigned and carried out, but results may be incomplete or inadequate. ... 

As discussed in Chapter 2, The Toller Selection Process, evaluating the site s safe work practice procedures should have been a part of the review during the toller selection process. Still, new materials may indicate a need to revise or develop special procedures to address unique chemical and physical hazards. New hazards such as vacuum, ciyogenics, ultra-high pressure, or new rotating equipment could be introduced. Medical monitoring requirements or special handling and spill response procedures for the toll s raw materials and products may indicate a need to write or revise safe work practices. 

As part of the ongoing assessment during the administration of naloxone, the nurse monitors the blood pressure, pulse, and respiratory rate at frequent intervals, usually every 5 minutes, until the patient responds. After the patient has shown response to the drug, the nurse monitors vital signs every 5 to 15 minutes. The nurse should notify tlie primary healdi care provider if any adverse drug reactions occur because additional medical treatment may be needed. The nurse monitors die respiratory rate, rhydun, and depdi pulse blood pressure and level of consciousness until the effects of die narcotics wear off. 

Inform the patient about the potential drug-drug interactions with warfarin, including over-the-counter medications and dietary supplements (Tables 7-8, 7-9, and 7-10). Instruct the patient to call the health care practitioner responsible for monitoring warfarin therapy before starting any new medications or dietary supplements. 

Patients with incomplete responses should contact their health care provider immediately for instructions, while those with a poor response should proceed directly to the emergency department.1 In the emergency department, baseline PEF measurements and oxygen saturation should be monitored. PEF should be monitored before and 15 to 20 minutes after bronchodilator administration. Treatment should be initiated as soon as lung function is assessed (Fig. 11-3). Dosages for emergency department and hospital use of quick relief medications are shown in Table 11-5. 

Biologic response modifiers (BRMs) are indicated in patients who have failed an adequate trial of DMARD therapy.1 BRMs may be added to DMARD monotherapy (i.e., methotrexate) or replace ineffective DMARD therapy.22 The decision to select a particular agent generally is based on the prescriber s comfort level with monitoring the safety and efficacy of the medications, the frequency and route of administration, the patient s comfort level or manual dexterity to self-administer subcutaneous injections, the cost, and the availability of insurance coverage.23 In general, BRMs should be avoided in patients with serious infections, demyelinating disorders (e.g., multiple sclerosis or optic neuritis) or heart failure.21... 

Clinicians should play a role in chemotherapy safety, patient education, and monitoring patient response to therapy. For example, cumulative doses of anthracyclines should be monitored along with signs and symptoms of heart failure. Clinicians also should monitor concurrent medications along with chemotherapy for drug interactions. 

Practitioners who design, implement, monitor, and evaluate medication therapy bear an important responsibility to their patients and society. Development of these abilities requires an integration of knowledge, skills, attitudes, and values that can be acquired only through a structured learning process that includes classroom work, independent study, hands-on practice, and, ultimately, involvement with actual patients. 

Ultrasensitive assays for PSA contribute to the earlier detection of prostate cancer relapse and (or) residual disease in prostatectomized patients as well as the more timely evaluation of response to current therapies. PSA determinations can be useful in detecting metastatic or persistent disease in patients following surgical or medical treatment of prostate cancer. Persistent elevation of PSA following treatment, or an increase in the pretreatment PSA concentrations, is indicative of recurrent or residual disease. Hence, PSA is widely accepted as an aid in the management of prostate cancer patients, and serum levels are most useful when sequential values are obtained and monitored over time. After complete removal of the prostate gland (radical prostatectomy), PSA levels should become very low or undetectable. A rise of the serum PSA level in prostatectomy patients indicates residual prostate tissue, recurrence, or metastasis of the disease (13, 16, 24, 36). 

Equipment and supply centers Medical emergency response Medical monitoring activities Sanitary facilities Supply, maintenance, and repair of communications, respiratory, and sampling equipment Maintenance and repair of vehicles Replacement of expendable supplies Storage of monitoring equipment and supplies—storage may be here or in an on-site field laboratory... 

---